Consumer

Struggling to Grow Flower Sales? Consumers Turning to Chill Pills

The Chill Pill brand Chill Pill brand, founded in 2018 in Arizona, quickly gained dominance within its product category for both medical and adult use consumers, PHOTO CHILL PILL

A new wave of cannabis consumers is looking for smokeless, rapid-onset products that are consistent. Betting on more buyers looking for an easy-to-pop cannabis solution, Ally Biotech, a provider of bioactive cannabinoid delivery solutions, this week announced the acquisition of the popular Chill Pill brand.

The Chill Pill brand, founded in 2018 by Andrew Provencio at Desert Medical Campus, offered the first THC soft gel cap on the market in Arizona. The product quickly gained dominance within its product category for both medical and adult use consumers, which it still maintains. The Chill Pill line is now distributed in nearly 40 licensed Arizona dispensaries.

Payson, AZ-based Ally Biotech President, Jim Mackowiak, said plans are underway to expand the Chill Pill line to include new products that are developed with highly bioavailable custom formulations.

The Chill Pill soft gel cap line includes:

Day Caps – a sativa-dominant formula. Anytime Caps – a formulation that combines sativa and indica.
Night Caps – an indica dominant formula.
Anytime Caps + CBD – a 1:1 blend of THC and CBD.
THC-A – Non-intoxicating symptom relief with no psychoactive effects.

For more information on Ally Biotech, visit AllyBiotech.com. For more information about the Chill Pill, visit ChillPillsAZ.com

Brad Cheng

Brad Cheng is the digital editor of Global Cannabis Times, produced by SmartWork Media. Brad's journalism career spans working as an editor for PR Newswire, The Nation and The Santa Barbara News Press, and as Managing Editor of The Katy Courier, and publisher of Now This in Princeton. His career as a screenwriter took him into entertainment advertising, writing major film campaigns for studios and for HBO.